PRENAVITE TABLETS 50 MG
IRON (FERROUS FUMARATE) : 50 MG CALCIUM (CALCIUM CARBONATE) : 125 MG VITAMIN D : 400 UNIT SODIUM ASCORBATE : 100 MG FOLIC ACID : 1 MG VITAMIN A ACETATE : 4000 UNIT · DIN 02063174 · ROBERTS PHARMACEUTICAL CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is PRENAVITE TABLETS?
PRENAVITE TABLETS 50 MG contains IRON (FERROUS FUMARATE) : 50 MG CALCIUM (CALCIUM CARBONATE) : 125 MG VITAMIN D : 400 UNIT SODIUM ASCORBATE : 100 MG FOLIC ACID : 1 MG VITAMIN A ACETATE : 4000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02063174, held by ROBERTS PHARMACEUTICAL CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02063174 |
|---|---|
| Brand name | PRENAVITE TABLETS |
| Generic / active ingredient | IRON (FERROUS FUMARATE) : 50 MG CALCIUM (CALCIUM CARBONATE) : 125 MG VITAMIN D : 400 UNIT SODIUM ASCORBATE : 100 MG FOLIC ACID : 1 MG VITAMIN A ACETATE : 4000 UNIT |
| Manufacturer | ROBERTS PHARMACEUTICAL CANADA INC. |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | B03AE04 IRON, MULTIVITAMINS AND MINERALS |
| AHFS class | 20:04.04 ; 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Aug-1999 |
| Original market date | 1995-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02063174 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2063174 |
| Brand name | PRENAVITE TABLETS |
| Active ingredient / INN | IRON (FERROUS FUMARATE) : 50 MG CALCIUM (CALCIUM CARBONATE) : 125 MG VITAMIN D : 400 UNIT SODIUM ASCORBATE : 100 MG FOLIC ACID : 1 MG VITAMIN A ACETATE : 4000 UNIT |
| ATC code | B03AE04 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B03 |
| AHFS class | 20:04.04 ; 88:28.01* ; See footnote |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | ROBERTS PHARMACEUTICAL CANADA INC. |
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code B03AE04 IRON, MULTIVITAMINS AND MINERALS. 2 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PREGVIT | 2 MG | TABLET | DUCHESNAY INC | MARKETED | DIN 02552620 |
| PREGVIT FOLIC 5 | 3.4 MG | TABLET | DUCHESNAY INC | MARKETED | DIN 02552639 |
| GESTAMINE COMPRIMES | 60 MG | TABLET | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00722227 |
| IRON PLUS MANGANESE, B12, FOLIC ACID & C | 10 MCG | TABLET | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | CANCELLED POST MARKET | DIN 00770760 |
| MATERNA - TAB | 25 MCG | TABLET | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02170043 |
| MATERNA TAB | 60 MG | TABLET | CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 01900587 |
| MATERNA-TAB | .15 MG | TABLET | LEDERLE CONSUMER HEALTH PRODUCTS | CANCELLED POST MARKET | DIN 02131277 |
| MATERNITY ONE MULTIVITAMIN WITH MINS CAPLET | 60 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 01918052 |
| NUTRIFER PLUS TAB | 150 MG | TABLET | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932683 |
| ORIFER F | 20 MG | TABLET | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 02103044 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.